Doug Schenkel Analyst PerformanceAnalyst at Wolfe ResearchDoug Schenkel is a stock analyst at Wolfe Research in the healthcare sector, covering 21 publicly traded companies. Over the past year, Doug Schenkel has issued 22 stock ratings, including buy and hold recommendations. While full access to Doug Schenkel's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Doug Schenkel's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings40 Last 11 YearsBuy Recommendations71.05% 27 Buy RatingsCompanies Covered21 Unique Companies Ratings Distribution38RatingsDistribution of strong buy, buy, hold, and sell ratings by Doug Schenkel.RatingPercentageCount Strong Buy0.0%0 ratings Buy71.1%27 ratings Hold28.9%11 ratings Sell0.0%0 ratingsOut of 38 total stock ratings issued by Doug Schenkel at Wolfe Research, the majority (71.1%) have been Buy recommendations, followed by 28.9% Hold.Best & Worst CallsBest Call000.0%AVTRFeb 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TBIOOct 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ57.1% of companies on NASDAQ12 companiesNYSE42.9% of companies on NYSE9 companiesDoug Schenkel, an analyst at Wolfe Research, currently covers 21 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare21 companies100.0%Doug Schenkel of Wolfe Research specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageLIFE SCIENCES TOOLS & SERVICES13 companies61.9%BIOTECHNOLOGY3 companies14.3%HEALTHCARE EQUIPMENT & SUPPLIES2 companies9.5%HEALTHCARE PROVIDERS & SERVICES2 companies9.5%HEALTHCARE TECHNOLOGY1 company4.8% Doug Schenkel's Ratings History at Wolfe Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsGRALGRAIL9/17/2026Set Price Target$75.11$84.00$0.0000.00% ROIHTFLHeartflow9/9/2026Initiated Coverage$47.75$55.00Neutral$0.0000.00% ROIGRALGRAIL9/9/2026Initiated Coverage$79.10$105.00Buy$0.0000.00% ROICAICaris Life Sciences9/9/2026Initiated Coverage$24.82$28.00Neutral$0.0000.00% ROIILMNIllumina9/9/2026Upgrade$211.06$260.00Buy$0.0000.00% ROIWATWaters9/9/2026Upgrade$408.52$490.00Buy$0.0000.00% ROIWSTWest Pharmaceutical Services9/9/2026Boost Price Target$339.55$415.00Buy$0.0000.00% ROIRVTYRevvity9/9/2026Initiated Coverage$122.45$140.00Neutral$0.0000.00% ROIPACBPacific Biosciences of California9/9/2026Initiated Coverage$1.31$1.35Neutral$0.0000.00% ROINTRANatera9/9/2026Boost Price Target$325.80$435.00Buy$0.0000.00% ROIMTDMettler-Toledo International9/9/2026Initiated Coverage$1,299.83$1,460.00Neutral$0.0000.00% ROICAICaris Life Sciences9/9/2026Initiated Coverage$24.34$28.00Hold$0.0000.00% ROIGRALGRAIL9/9/2026Initiated Coverage$76.23$105.00Buy$0.0000.00% ROIHTFLHeartflow9/9/2026Initiated Coverage$49.88$55.00Hold$0.0000.00% ROIQGENQiagen9/9/2026Lower Price Target$42.39$47.00Hold$0.0000.00% ROIVCYTVeracyte9/9/2026Boost Price Target$40.87$65.00Buy$0.0000.00% ROITEMTempus AI9/9/2026Initiated Coverage$64.29$70.00Neutral$0.0000.00% ROITWSTTwist Bioscience9/9/2026Initiated Coverage$128.06$144.00Neutral$0.0000.00% ROITMOThermo Fisher Scientific9/8/2026Upgrade$603.43$730.00Buy$0.0000.00% ROIBRKRBruker12/10/2025Upgrade$45.36$60.00Outperform$0.0000.00% ROIWATWaters12/10/2025Upgrade$386.16$480.00Outperform$0.0000.00% ROIGHGuardant Health9/25/2025Upgrade$57.67$75.00Outperform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenWeiss RatingsUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank Aktiengesellschaft Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
